Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug 1;8(8):9154-60.
eCollection 2015.

MiR-451, a potential prognostic biomarker and tumor suppressor for gastric cancer

Affiliations

MiR-451, a potential prognostic biomarker and tumor suppressor for gastric cancer

Zhongxue Su et al. Int J Clin Exp Pathol. .

Abstract

Background: The expression of microRNA-451 (miR-451) and its association with clinical pathological factors in GC remain still unclear. The purpose of this study was to investigate if miR-451 is a potential prognostic biomarker and tumor suppressor for gastric cancer.

Methods: Real-time quantitative RT-PCR (qRT-PCR) was applied to detect miR-451 expression in GC cell lines and primary tumor and paired non-cancerous tissues. The association of miR-451 expression with clinicopathological factors and prognosis was statistically analyzed.

Results: We found that miR-451 showed decreased expression in GC tissues and cell lines, and its down-regulation tended to be positively correlated with lymphatic metastasis, clinical staging and shorter overall survival of patients. In addition, forced expression of miR-451 in BGC-823 and MKN-45 cells did not impact on cell proliferation, but did reduce migration and invasion rates in BGC-823 cells.

Conclusion: Our findings indicated that miR-451 may act as a novel prognostic marker and potential therapeutic target in human GC.

Keywords: MiR-451; gastric cancer; metastasis; prognosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Expression of miR-451 in gastric cancer (GC) tissues and cell lines. The expression levels of miR-451 were determined by qRT-PCR. A. Pairwise comparison of miR-451 expression between GC and matching non-cancerous tissues showing miR-451 expression was reduced in 28% (30/107) of the sample pairs. The expression level of miR-451 was calculated by the 2-ΔCt method, after normalized to U6 RNA. B. MiR-451 expression was reduced in four human GC cell lines: MKN-45, BGC-823, MKN-28, and SGC-7901 cells, when compared to that in normal gastric GES cells. Data were represented as mean ± SD from three independent experiments (*P < 0.05, **P < 0.01, ***P < 0.001).
Figure 2
Figure 2
Overall survival curves for two groups defined as low and high expression of miR-451 in GC patients. Lower miR-451 expression was significantly associated with poorer outcome of patients (P < 0.05, log-rank test).
Figure 3
Figure 3
Effects of miR-451 over-expression on GC cell proliferation. A. The expression level of miR-451 in miR-451 containing lentivirus infected cells was significantly higher compared with negative control (NC) transfected cells. qRT-PCR was done to detect the expression of miR-451 in three independent experiments. U6 small nuclear RNA was used as the internal control. ***P < 0.001, **P < 0.01. B. Cell proliferation was measured by MTT assays in BGC-823 and MKN-45 cells infected with miR-451 or NC containing lentivirus. The plates were read every one day for 5 consecutive days. Data were represented as mean ± SD from the experiments performed in triplicate.
Figure 4
Figure 4
MiR-451 inhibits GC cell migration and invasion in vitro. Over-expression of miR-451 significantly inhibited abilities of cell migration and invasion in miR-451-expressing stable BGC-823 cells compared with NC group. Data were expressed as the mean ± SD of at least three independent experiments (*P < 0.05). The migration and matrigel invasion assays showed that the number of migrated or invaded cells was significantly lower in the miR-451-overexpressed group than in the NC group (**P < 0.01).

References

    1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. - PubMed
    1. Moore MA, Eser S, Igisinov N, Igisinov S, Mohagheghi MA, Mousavi-Jarrahi A, Ozentürk G, Soipova M, Tuncer M, Sobue T. Cancer epidemiology and control in North-Western and Central Asia-past, present and future. Asian Pac J Cancer Prev. 2010;11(Suppl 2):17–32. - PubMed
    1. Chen W, Zheng R, Zeng H, Zhang S, He J. Annual report on status of cancer in China, 2011. Chin J Cancer Res. 2015;27:2–12. - PMC - PubMed
    1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29. - PubMed
    1. Gallo A, Cha C. Updates on esophageal and gastric cancers. World J Gastroenterol. 2006;12:3237–3242. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources